Romosozumab, used in osteoporosis treatment, may offer dual benefits by also reducing the risk for osteoarthritis, notably knee osteoarthritis.

IL-1 is considered one of the key mediators involved in the pathogenesis of OA, causing inflammation, joint pain, and ...

Higher UPF-consumption was linked to worse knee OA outcomes among women, including higher pain scores, worse physical function, and thinner knee cartilage.

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

Osteoarthritis (OA) is the most common form of arthritis, affecting over 32 million Americans. According to the World Health ...

Some key factors which increased the risk of developing knee osteoarthritis included being overweight or obese, past knee ...

Medical device company Overture Orthopaedics has commercially launched the OvertureTi Knee Resurfacing System.  The system is utilized to treat early osteoarthritis and cartilage defects, and includes ...

Combining HA with PRP is synergistic, according to a new, well designed, randomized study of knee OA. But…pain relief, no ...

Contrary to popular belief, osteoarthritis may not just be the result of wear and tear accrued over the course of a long life ...